Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
For best results when printing this announcement, please click on link below: Aptar Announces CE Marking for LuerVax(® )and Accompanying Spray Divider, Strengthening Support for Vaccine Developers Milestone strengthens Aptar Pharma’s support for intranasal vaccine development from clinical studies through commercializa